Alvotech
Price & Volume
Stats
See more52W Range | $2.94-$9.25 |
Market Cap | $1.7B |
Shares Short | 5M |
Financials
See moreRevenue (12 Mos) | $494.6M |
Revenue Growth (YoY) | -38.9% |
Gross Profit (12 Mos) | $300M |
Diluted EPS | -$0.61 |
News
See moreYahoo Finance • 4 days ago
Alvotech advances 18%, accelerating post-earnings rally
Yahoo Finance • 4 days ago
BofA starts bullish Alvotech coverage on biosimilar launch cycle
Yahoo Finance • 7 days ago
Alvotech Announces Licensing and Commercialization Agreement with Lotus Pharmaceutical for proposed biosimilars to durvalumab and emicizumab in the U.S. and Selected Asian Markets
Yahoo Finance • 8 days ago
Alvotech Q2 Earnings Call Highlights
About
Address | 9, Rue de Bitbourg, Luxembourg, Luxembourg, 1273 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 1,279 |